Concepedia

Chuangxing Guo

CG

27

Publications

1.6K

Citations

21

H-Index

1994

Active since

Affiliations

Pfizer (United States)(Current)

Purdue University West Lafayette

National Cancer Institute

University at Albany, State University of New York

University of British Columbia

Chuangxing Guo is an author at Pfizer (United States) specializing in medicine, pharmacology, and biochemistry.

Top concepts

Publications per year

1994–2014

27

Publications

27

Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth

Brion W. Murray, Chuangxing Guo, Joseph Piraino et al. · Proceedings of the National Academy of Sciences · 2010 · 318 citations · Full text

Interphylal Product Splicing:  The First Total Syntheses of Cephalostatin 1, the North Hemisphere of Ritterazine G, and the Highly Active Hybrid Analogue, Ritterostatin G<sub>N</sub>1<sub>N</sub><sup>1</sup>

Thomas Lacour, Chuangxing Guo, Sudhakar Bhandaru et al. · Journal of the American Chemical Society · 1998 · 110 citations

, , +21

Structure-based design of novel human Pin1 inhibitors (I)

Chuangxing Guo, Xinjun Hou, Liming Dong et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 105 citations · Full text

, , +4

Structure-based design of novel human Pin1 inhibitors (II)

Liming Dong, Joseph Marakovits, Xinjun Hou et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 86 citations

, , +4

Systematic Structure Modifications of Imidazo[1,2-<i>a</i>]pyrimidine to Reduce Metabolism Mediated by Aldehyde Oxidase (AO)

Angelica Linton, Ping Kang, Martha A. Ornelas et al. · Journal of Medicinal Chemistry · 2011 · 80 citations

, , +22

Rows per page

1–5 of 27